Market revenue in 2023 | USD 14.7 million |
Market revenue in 2030 | USD 33.3 million |
Growth rate | 12.4% (CAGR from 2023 to 2030) |
Largest segment | Ferric carboxymaltose |
Fastest growing segment | Ferric Carboxymaltose |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 49.66% in 2023. Horizon Databook has segmented the Saudi Arabia intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
The intravenous iron drugs market in Saudi Arabia is expected to grow at a lucrative rate over the forecast period, owing to the rapid launch of new products in the region and increasing number of government initiatives.
The completion of the study and the inclusion of medication under insurance are expected to increase patient access to treatments and, as a result, boost the demand for medicines over the forecast period. CKD burden is higher in Saudi Arabia as compared to the western world.
Based on data published in the International Journal of Nephrology published in 2019, around 6% of the total population had CKD, of which, only 7.1% were aware of their disease status. According to Globo can 2020, 27,885 cancer cases were recorded in 2020 in Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account